Krsnaa Diagnostics Ltd's Q3FY25 Quarter Results
- 13 Feb 2025
Result Summary
- Krsnaa Diagnostics Ltd reported a 3.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 13.1%.
- Its expenses for the quarter were down by 4.4% QoQ and up 8.2% YoY.
- The net profit decreased 0.9% QoQ and increased 49.7% YoY.
- The earnings per share (EPS) of Krsnaa Diagnostics Ltd stood at 5.9 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 183.75 | 190.93 | 162.40 | -3.8% | 13.1% |
Total Expenses | 158.27 | 165.53 | 146.30 | -4.4% | 8.2% |
Profit Before Tax | 25.48 | 25.40 | 16.10 | 0.3% | 58.3% |
Tax | 6.06 | 5.81 | 3.12 | 4.3% | 94.2% |
Profit After Tax | 19.42 | 19.60 | 12.97 | -0.9% | 49.7% |
Earnings Per Share | 5.90 | 5.90 | 4.00 | 0.0% | 47.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Krsnaa Diagnostics Ltd is a company operating within the healthcare sector, primarily engaged in offering diagnostic and laboratory services. It provides a variety of diagnostic services such as imaging, pathology, and tele-radiology, catering to hospitals, healthcare institutions, and individual patients. As an emerging player in the diagnostics industry, Krsnaa Diagnostics has been expanding its footprint by setting up diagnostic centers across various locations. The company is positioned to capitalize on the growing demand for healthcare services, driven by increasing awareness and the need for advanced diagnostic solutions.
Revenue
During the third quarter of fiscal year 2025 (Q3FY25), Krsnaa Diagnostics Ltd reported a total income of ₹183.75 crores. This represents a decrease of 3.8% compared to the previous quarter (Q2FY25), where the total income was ₹190.93 crores. However, when compared to the same quarter of the previous year (Q3FY24), the company experienced a 13.1% increase in total income, which was ₹162.40 crores in Q3FY24. This year-over-year growth reflects an upward trend in revenue generation, indicating an expansion in the company's business activities over the past year.
Profitability
Krsnaa Diagnostics Ltd's profitability for Q3FY25 is highlighted by a Profit Before Tax (PBT) of ₹25.48 crores, which shows a marginal increase of 0.3% from Q2FY25's PBT of ₹25.40 crores. Compared to the previous year's corresponding quarter (Q3FY24), there is a significant 58.3% increase from ₹16.10 crores. The company incurred a tax expense of ₹6.06 crores in Q3FY25, reflecting a 4.3% rise from Q2FY25 and a substantial 94.2% increase compared to Q3FY24. Consequently, the Profit After Tax (PAT) for Q3FY25 stood at ₹19.42 crores, slightly down by 0.9% from the previous quarter's ₹19.60 crores, but up by 49.7% from ₹12.97 crores in Q3FY24. Earnings Per Share (EPS) remained constant at ₹5.90 compared to the previous quarter, while showcasing a 47.5% improvement from ₹4.00 in the previous year.
Operating Metrics
The operational efficiency of Krsnaa Diagnostics Ltd can be gauged by examining its expenditure patterns. The total expenses for Q3FY25 amounted to ₹158.27 crores, a decrease of 4.4% from the previous quarter's expenses of ₹165.53 crores, yet an 8.2% rise from ₹146.30 crores in Q3FY24. This decline in sequential expenses indicates a potential improvement in cost management or reduced operational activities in the recent quarter. The stable Earnings Per Share amidst varying profitability metrics suggests consistent operational performance relative to the company’s equity structure. The data does not provide specific details on operational ratios or other metrics such as debt-to-equity or current ratios, which would further elucidate the company’s operational stance.
